$0.000.00 |(%)
About CTY
- Industry:
- Exchange:
- Country:
Frequently Asked Questions
What is the 52-week range for CTY?
The 52-week high is $ and the 52-week low is $.
What is the P/E ratio for CTY?
The P/E ratio data is currently unavailable.
What is the dividend yield for CTY?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
ROE data is currently unavailable.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Latest CTY News
City Therapeutics, RNAi Treatment Developer, Files For IPO
City Therapeutics is advancing next-generation RNAi therapeutics, with its lead program, CITY-FXI, targeting thrombosis. Click here to read this CTY update.
SeekingAlpha9/29/2026
U.S. IPO Weekly Recap: Postponed Deals Put Damper On Fall IPO Market
One IPO and two SPACs debuted this week, although more deals were originally on the calendar. Read more here.
SeekingAlpha9/25/2026